Aimfinity Investment Corp. I (NasdaqGM:AIMA.U) agreed to acquire Docter Inc. for $91 million on October 13, 2023. The deal has been approved by board of directors, and is still subject to shareholder's approval of Aimfinity Investment Corp.

I, and regulatory board. The transaction is expected to close on or before April 28, 2024.Capital Markets Advisors, LLC and Robinson & Cole LLP acted as legal advisor, and US Tiger Securities is serving as M&A advisor to Aimfinity Investment Corp. I, and Mike Blankenship, Dean Hinderliter and Susan Deng of Winston & Strawn LLP acted as legal advisor to Docter Inc.